(Q54281368)

27 May 2018

title

In vitro analysis of drug resistance in tumor cells from patients with acute myelocytic leukemia. (English)

1 reference

27 May 2018

4

P Nygren

1 reference

27 May 2018

5

R Larsson

1 reference

27 May 2018

J Kristensen

1

1 reference

27 May 2018

B Jonsson

series ordinal

2

1 reference

27 May 2018

C Sundström

series ordinal

3

1 reference

27 May 2018

publication date

1 January 1992

1 reference

27 May 2018

Medical oncology and tumor pharmacotherapy

published in

1 reference

27 May 2018

volume

9

1 reference

27 May 2018

issue

2

1 reference

27 May 2018

page(s)

65-74

1 reference

27 May 2018

Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine

cites work

1 reference

12 December 2020

Comparative effectiveness of mitoxantrone and doxorubicin in overcoming experimentally induced drug resistance in murine and human tumour cell lines in vitro

1 reference

12 December 2020

Determinants of response and prediction of response to chemotherapy in acute myelogenous leukemia

1 reference

12 December 2020

Differential in vitro sensitivity of human tumor and normal cells to chemotherapeutic agents and resistance modulators

1 reference

12 December 2020

MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia.

1 reference

12 December 2020

The cell biology of multiple drug resistance

1 reference

12 December 2020

P-glycoprotein expression and in vitro reversion of doxorubicin resistance by verapamil in clinical specimens from acute leukaemia and myeloma

1 reference

12 December 2020

Highly specific prediction of antineoplastic drug resistance with an in vitro assay using suprapharmacologic drug exposures.

1 reference

12 December 2020

Pharmacological modification of multi-drug resistance (MDR) in vitro detected by a novel fluorometric microculture cytotoxicity assay. Reversal of resistance and selective cytotoxic actions of cyclosporin A and verapamil on MDR leukemia T-cells

1 reference

12 December 2020

Semi-micro adaptation of a 4-day differential staining cytotoxicity (DiSC) assay for determining the in-vitro chemosensitivity of haematological malignancies

1 reference

12 December 2020

Laboratory detection of primary and acquired drug resistance in human lymphatic neoplasms.

1 reference

12 December 2020

High-dose cytosine arabinoside and mitoxantrone: a highly effective regimen in refractory acute myeloid leukemia

1 reference

12 December 2020

Correlations between therapeutic response of leukaemias and in-vitro drug-sensitivity assay

1 reference

12 December 2020

Drug resistance mechanisms in leukaemia

1 reference

12 December 2020

MDR1 gene expression and treatment outcome in acute myeloid leukemia.

1 reference

12 December 2020

Clinical pharmacokinetics-pharmacodynamics of anticancer drugs

1 reference

12 December 2020

Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin-sensitive and -resistant P388 leukemia cell lines

1 reference

12 December 2020

Protooncogene expression and the clinical characteristics of acute nonlymphocytic leukemia: A Leukemia Intergroup pilot study.

1 reference

12 December 2020

Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity

1 reference

12 December 2020

Expression of the multidrug resistance gene in myeloid leukemias.

1 reference

12 December 2020

Chemotherapeutic drug sensitivity testing of human leukemia cells in vitro using a semiautomated fluorometric assay

1 reference

12 December 2020

Chemosensitivity testing of fresh human leukemia cells using both a dye exclusion assay and a tetrazolium dye (MTT) assay.

1 reference

12 December 2020

Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.

1 reference

12 December 2020

Rationales for a pharmacologically optimized treatment of acute nonlymphocytic leukemia with cytosine arabinoside.

1 reference

12 December 2020

Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia

1 reference

12 December 2020

Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein

1 reference

12 December 2020

Increased P-glycoprotein expression and multidrug-resistant gene (mdr1) amplification are infrequently found in fresh acute leukemia cells. Sequential analysis of 15 cases at initial presentation and relapsed stage

1 reference

12 December 2020

Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA)

1 reference

12 December 2020

Combination of mitoxantrone and etoposide in refractory acute myelogenous leukemia--an active and well-tolerated regimen

1 reference

12 December 2020

In vitro chemosensitivity of newly diagnosed and relapsing acute non-lymphoid leukemia patients

1 reference

12 December 2020

Cellular and pharmacologic aspects of drug resistance in acute myeloid leukemia

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02989656

0 references

1 reference

27 May 2018